[An update on diabetic retinopathy].
Diabetic retinopathy is the most common microvascular complication of diabetes mellitus. Research performed over the last several decades has demonstrated the benefit of systemic control and ocular treatments in reducing the risk of blindness. In the Western world, however, diabetic retinopathy remains the major cause of blindness in the working age population and its economical impact is the highest among the different ocular diseases. This review discusses the various aspects of diabetic retinopathy and includes an update on new research in the field.
Rechtman
Ehud
E
Retina Unit, Goldschleger Eye Institute, Sheba Medical Center, Tel Hashomer, Israel. ehudrechtman@yahoo.com
Harris
Alon
A
D001766:Blindness / Q000517:prevention & control; D002986:Clinical Trials as Topic; D003930:Diabetic Retinopathy / Q000453:epidemiology / Q000473:pathology / Q000503:physiopathology* / Q000517:prevention & control; D006801:Humans; D015994:Incidence